IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab

IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab

Giorgia Marisi,1 Emanuela Scarpi,2 Alessandro Passardi,3 Oriana Nanni,2 Flavia Pagan,2 Martina Valgiusti,3 Andrea Casadei Gardini,3 Luca Maria Neri,4 Giovanni Luca Frassineti,3 Dino Amadori,3 Paola Ulivi1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRS...

Full description

Bibliographic Details
Main Authors: Marisi G, Scarpi E, Passardi A, Nanni O, Pagan F, Valgiusti M, Casadei Gardini A, Neri LM, Frassineti GL, Amadori D, Ulivi P
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Cancer Management and Research
Subjects:
serum biomarkers
targeted therapy
IL-8
angiogenesis
chemotherapy
Online Access:https://www.dovepress.com/il-8-and-thrombospondin-1-as-prognostic-markers-in-patients-with-metas-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/il-8-and-thrombospondin-1-as-prognostic-markers-in-patients-with-metas-peer-reviewed-article-CMAR

Similar Items